Drug Pricing ‘Not Appropriate Topic’ For WTO TRIPS Council
US And EU Defend Current Innovation Model
Executive Summary
The World Trade Organization is not the place to discuss pharmaceutical pricing, and strong intellectual property rights do not threaten access to medicines, according to EU and US delegations to the WTO.